MedTrace Logo

Evaluation of Multiprofessional Group Programs for Paediatric Obesity Therapy

NCT03233425 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1152

Last updated 2017-07-28

No results posted yet for this study

Summary

The aim of this pilot project is to disseminate multiprofessional group programs (\*MGP\*) for therapy of the estimated 119'140 overweight/obese children in Switzerland. Family-based behavioral MGPs have been implemented from 2009 to 2013 to determine changes of health and family behaviours, after the intensive phase (\*T1\*), at 1 and 2 years after start (\*T2\*, \*T3\*). MGP costs are reimbursed in Switzerland: 1) if 116 sessions are provided by experts in physical activity, nutrition and psychology; 2) if parents are included and if their adherence is higher than 85%. In the nationwide "Evaluation of Multiprofessional Group Programs for Paediatric Obesity Therapy" (\*KIDSSTEP\*) study, multiple psychosocial and physical parameters were assessed at T0, T2 and T3 . Out of 33 certified centers, 25 were active and only 19 were re-certified in 2013/2014. Obese children suffer from major co-morbidities and therefore, only one third of referred patients can be treated in MGPs and their beneficial effects on obesity as well as physical and mental health outcomes are sustained over 2 years.

Conditions

Interventions

BEHAVIORAL

multiprofessional group therapy

Behavioural therapy of lifestyle including activity, family and eating habits

Sponsors & Collaborators

  • University Hospital, Geneva

    collaborator OTHER

  • akj, Fachverband Adipositas im Kindes- und Jugendalter, Switzerland

    collaborator UNKNOWN

  • Federal Office of Public Health, Switzerland

    collaborator OTHER_GOV

  • Ostschweizer Kinderspital

    lead OTHER

Principal Investigators

  • Dagmar lAllemand, Pr · Ostschweizer Kinderspital, St. Gallen, Switzerland

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2013-12-31
Completion
2014-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03233425 on ClinicalTrials.gov